Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Melanin-concentrating hormone acts through hypothalamic kappa opioid system and p70S6K to stimulate acute food intake

  • Romero-Picó, Amparo
  • Sanchez-Rebordelo, Estrella
  • Imbernon, Monica
  • Gónzalez-Touceda, David
  • Folgueira, Cintia
  • Senra, Ana
  • Fernø, Johan
  • Blouet, Clémence
  • Cabrera Ortega, Roberto
  • Gestel, Margriet van
  • Adan, Roger A.
  • López, Miguel
  • Maldonado, Rafael, 1961-
  • Nogueiras, Ruben
  • Diéguez, Carlos
Melanin-Concentrating Hormone (MCH) is one of the most relevant orexigenic factors specifically located in the lateral hypothalamic area (LHA), with its physiological relevance demonstrated in studies using several genetically manipulated mice models. However, the central mechanisms controlling MCH-induced hyperphagia remain largely uncharacterized. Here, we show that central injection of MCH in mice deficient for kappa opoid receptor (k-OR) failed to stimulate feeding. To determine the hypothalamic area responsible for this MCH/k-OR interaction, we performed virogenetic studies and found that downregulation of k-OR by adeno-associated viruses (shOprk1-AAV) in LHA, but not in other hypothalamic nuclei, was sufficient to block MCH-induced food intake. Next, we sought to investigate the molecular signaling pathway within the LHA that mediates acute central MCH stimulation of food intake. We found that MCH activates k-OR and that increased levels of phosphorylated extracellular signal regulated kinase (ERK) are associated with downregulation of phospho-S6 Ribosomal Protein. This effect was prevented when a pharmacological inhibitor of k-OR was co-administered with MCH. Finally, the specific activation of the direct upstream regulator of S6 (p70S6K) in the LHA attenuated MCH-stimulated food consumption. Our results reveal that lateral hypothalamic k-OR system modulates the orexigenic action of MCH via the p70S6K/S6 pathway., This work has been supported by grants from Ministerio de Economia y Competitividad (CD: BFU2014-55871; RN: BFU2015-70664-R; ML: SAF2015-71026-R), Xunta de Galicia (ML: 2015- CP079; RN: 2015-CP080 and PIE13/00024); Fundacion SEEN (RN); Helse Vest RHF (JF); Fundación AstraZeneca (RN: 2016-PO031); Centro de Investigacion Biomédica en Red (CIBER) de Fisiopatología de la Obesidad y Nutricion (CIBERobn). CIBERobn is an initiative of the Instituto de Salud Carlos III (ISCIII) of Spain which is supported by FEDER funds. The research leading to these results has also received funding from the European Community's Seventh Framework Programme under the following grant: RN: ERC StG281408
Repisalud
Publication Artículo científico (JournalArticle)

Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis

  • Porteiro, Begona
  • Fondevila, Marcos F.
  • Buque, Xabier
  • Gonzalez-Rellan, Maria J.
  • Fernandez, Uxia
  • Mora, Alfonso
  • Beiroa, Daniel
  • Senra, Ana
  • Gallego, Rosalia
  • Ferno, Johan
  • Lopez, Miguel
  • Sabio, Guadalupe
  • Dieguez, Carlos
  • Aspichueta, Patricia
  • Nogueiras, Ruben
Objective: Recent reports have implicated the p53 tumor suppressor in the regulation of lipid metabolism. We hypothesized that the pharmacological activation of p53 with low-dose doxorubicin, which is widely used to treat several types of cancer, may have beneficial effects on nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). Methods: We used long-term pharmacological activation of p53 by i.p. or oral administration of low-dose doxorubicin in different animal models of NAFLD (high fat diet containing 45\% and 60\% kcal fat) and NASH (methionine- and choline-deficient diet and choline deficiency combined with high fat diet). We also administered doxorubicin in mice lacking p53 in the liver and in two human hepatic cells lines (HepG2 and THLE2). Results: The attenuation of liver damage was accompanied by the stimulation of fatty acid oxidation and decrease of lipogenesis, inflammation, and ER stress. The effects of doxorubicin were abrogated in mice with liver-specific ablation of p53. Finally, the effects of doxorubicin on lipid metabolism found in animal models were also present in two human hepatic cells lines, in which the drug stimulated fatty acid oxidation and inhibited de novo lipogenesis at doses that did not cause changes in apoptosis or cell viability. Conclusion: These data provide new evidence for targeting p53 as a strategy to treat liver disease. (C) 2017 The Authors. Published by Elsevier GmbH.
Repisalud
Publication Artículo científico (JournalArticle)

Hepatic p63 regulates steatosis via IKK beta/ER stress

  • Porteiro, Begona
  • Fondevila, Marcos F.
  • Delgado, Teresa C.
  • Iglesias, Cristina
  • Imbernon, Monica
  • Iruzubieta, Paula
  • Crespo, Javier
  • Zabala-Letona, Amaia
  • Ferno, Johan
  • Gonzalez-Teran, Barbara
  • Matesanz, Nuria
  • Hernandez-Cosido, Lourdes
  • Marcos, Miguel
  • Tovar, Sulay
  • Vidal, Anxo
  • Sanchez-Ceinos, Julia
  • Malagon, Maria M.
  • Pombo, Celia
  • Zalvide, Juan
  • Carracedo, Arkaitz
  • Buque, Xabier
  • Dieguez, Carlos
  • Sabio, Guadalupe
  • Lopez, Miguel
  • Aspichueta, Patricia
  • Martinez-Chantar, Maria L.
  • Nogueiras, Ruben
p53 family members control several metabolic and cellular functions. The p53 ortholog p63 modulates cellular adaptations to stress and has a major role in cell maintenance and proliferation. Here we show that p63 regulates hepatic lipid metabolism. Mice with liver-specific p53 deletion develop steatosis and show increased levels of p63. Down-regulation of p63 attenuates liver steatosis in p53 knockout mice and in diet-induced obese mice, whereas the activation of p63 induces lipid accumulation. Hepatic overexpression of N-terminal transactivation domain TAp63 induces liver steatosis through IKK beta activation and the induction of ER stress, the inhibition of which rescues the liver functions. Expression of TAp63, IKK beta and XBP1s is also increased in livers of obese patients with NAFLD. In cultured human hepatocytes, TAp63 inhibition protects against oleic acid-induced lipid accumulation, whereas TAp63 overexpression promotes lipid storage, an effect reversible by IKK beta silencing. Our findings indicate an unexpected role of the p63/IKK beta/ER stress pathway in lipid metabolism and liver disease.
Repisalud
Publication Artículo científico (JournalArticle)

p53 in AgRP neurons is required for protection against diet-induced obesity via JNK1

  • Quinones, Mar
  • Al-Massadi, Omar
  • Folgueira, Cintia
  • Bremser, Stephan
  • Gallego, Rosalia
  • Torres-Leal, Leonardo
  • Haddad-Tovolli, Roberta
  • Garcia-Caceres, Cristina
  • Hernandez-Bautista, Rene
  • Lam, Brian Y. H.
  • Beiroa, Daniel
  • Sanchez-Rebordelo, Estrella
  • Senra, Ana
  • Malagon, Jose A.
  • Valerio, Patricia
  • Fondevila, Marcos F.
  • Ferno, Johan
  • Malagon, Maria M.
  • Contreras, Raian
  • Pfluger, Paul
  • Bruening, Jens C.
  • Yeo, Giles
  • Tschoep, Matthias
  • Dieguez, Carlos
  • Lopez, Miguel
  • Claret, Marc
  • Kloppenburg, Peter
  • Sabio, Guadalupe
  • Nogueiras, Ruben
p53 is a well-known tumor suppressor that has emerged as an important player in energy balance. However, its metabolic role in the hypothalamus remains unknown. Herein, we show that mice lacking p53 in agouti-related peptide (AgRP), but not proopiomelanocortin (POMC) or steroidogenic factor-1 (SF1) neurons, are more prone to develop diet-induced obesity and show reduced brown adipose tissue (BAT) thermogenic activity. AgRP-specific ablation of p53 resulted in increased hypothalamic c-Jun N-terminal kinase (JNK) activity before the mice developed obesity, and central inhibition of JNK reversed the obese phenotype of these mice. The overexpression of p53 in the ARC or specifically in AgRP neurons of obese mice decreased body weight and stimulated BAT thermogenesis, resulting in body weight loss. Finally, p53 in AgRP neurons regulates the ghrelin-induced food intake and body weight. Overall, our findings provide evidence that p53 in AgRP neurons is required for normal adaptations against diet-induced obesity.
Repisalud
Publication Artículo científico (JournalArticle)

p38α blocks brown adipose tissue thermogenesis through p38δ inhibition

  • Matesanz, Nuria
  • Nikolic, Ivana
  • Leiva, Magdalena
  • Pulgarin-Alfaro, Marta
  • Santamans, Ayelen M
  • Bernardo, Edgar
  • Mora, Alfonso
  • Herrera-Melle, Leticia
  • Rodriguez, Elena
  • Beiroa, Daniel
  • Caballero, Ainoa
  • Martin-Garcia, Elena
  • Acin-Perez, Rebeca
  • Hernández-Cosido, Lourdes
  • Leiva-Vega, Luis
  • Torres, Jorge L
  • Centeno, Francisco
  • Nebreda, Angel R
  • Enriquez, Jose Antonio
  • Nogueiras, Rubén
  • Marcos, Miguel
  • Sabio, Guadalupe
Adipose tissue has emerged as an important regulator of whole-body metabolism, and its capacity to dissipate energy in the form of heat has acquired a special relevance in recent years as potential treatment for obesity. In this context, the p38MAPK pathway has arisen as a key player in the thermogenic program because it is required for the activation of brown adipose tissue (BAT) thermogenesis and participates also in the transformation of white adipose tissue (WAT) into BAT-like depot called beige/brite tissue. Here, using mice that are deficient in p38α specifically in adipose tissue (p38αFab-KO), we unexpectedly found that lack of p38α protected against high-fat diet (HFD)-induced obesity. We also showed that p38αFab-KO mice presented higher energy expenditure due to increased BAT thermogenesis. Mechanistically, we found that lack of p38α resulted in the activation of the related protein kinase family member p38δ. Our results showed that p38δ is activated in BAT by cold exposure, and lack of this kinase specifically in adipose tissue (p38δ Fab-KO) resulted in overweight together with reduced energy expenditure and lower body and skin surface temperature in the BAT region. These observations indicate that p38α probably blocks BAT thermogenesis through p38δ inhibition. Consistent with the results obtained in animals, p38α was reduced in visceral and subcutaneous adipose tissue of subjects with obesity and was inversely correlated with body mass index (BMI). Altogether, we have elucidated a mechanism implicated in physiological BAT activation that has potential clinical implications for the treatment of obesity and related diseases such as diabetes.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet

  • Beiroa Tarrío, Daniel
  • Romero Picó, Amparo
  • Langa, Carmen
  • Bernabeu, Carmelo
  • López Pérez, Miguel A.
  • López Novoa, José M.
  • Nogueiras Pozo, Rubén
  • Diéguez González, Carlos
Endoglin is a transmembrane auxiliary receptor for transforming growth factor-beta (TGF-beta) that is predominantly expressed on proliferating endothelial cells. It plays a wide range of physiological roles but its importance on energy balance or insulin sensitivity has been unexplored. Endoglin deficient mice die during midgestation due to cardiovascular defects. Here we report for first time that heterozygous endoglin deficiency in mice decreases high fat diet-induced hepatic triglyceride content and insulin levels. Importantly, these effects are independent of changes in body weight or adiposity. At molecular level, we failed to detect relevant changes in the insulin signalling pathway at basal levels in liver, muscle or adipose tissues that could explain the insulin-dependent effect. However, we found decreased triglyceride content in the liver of endoglin heterozygous mice fed a high fat diet in comparison to their wild type littermates. Overall, our findings indicate that endoglin is a potentially important physiological mediator of insulin levels and hepatic lipid metabolism.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Female Nur77-deficient mice show increased susceptibility to diet-induced obesity

  • Pérez Sieira, Sonia
  • Martínez, Gloria
  • Porteiro Couto, Begoña
  • López Pérez, Miguel A.
  • Vidal Figueroa, Anxo
  • Nogueiras Pozo, Rubén
  • Diéguez González, Carlos
Adipose tissue is essential in the regulation of body weight. The key process in fat catabolism and the provision of energy substrate during times of nutrient deprivation or enhanced energy demand is the hydrolysis of triglycerides and the release of fatty acids and glycerol. Nur77 is a member of the NR4A subfamily of nuclear receptors that plays an important metabolic role, modulating hepatic glucose metabolism and lipolysis in muscle. However, its endogenous role on white adipose tissue, as well as the gender dependency of these mechanisms, remains largely unknown. Male and female wild type and Nur77 deficient mice were fed with a high fat diet (45% calories from fat) for 4 months. Mice were analyzed in vivo with the indirect calorimetry system, and tissues were analyzed by real-time PCR and Western blot analysis. Female, but not male Nur77 deficient mice, gained more weight and fat mass when compared to wild type mice fed with high fat diet, which can be explained by decreased energy expenditure. The lack of Nur77 also led to a decreased pHSL/HSL ratio in white adipose tissue and increased expression of CIDEA in brown adipose tissue of female Nur77 deficient mice. Overall, these findings suggest that Nur77 is an important physiological modulator of lipid metabolism in adipose tissue and that there are gender differences in the sensitivity to deletion of the Nur77 signaling. The decreased energy expenditure and the actions of Nur77 on liver, muscle, brown and white adipose tissue contribute to the increased susceptibility to diet-induced obesity in females lacking Nur77.
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Regulation of Chemerin and CMKLR1 Expression by Nutritional Status, Postnatal Development, and Gender

  • Sánchez Rebordelo, María Estrella
  • Cuñarro Gómez, Juan
  • Pérez Sieira, Sonia
  • Seoane Camino, Luisa María
  • Diéguez González, Carlos
  • Nogueiras Pozo, Rubén
  • Tovar Carro, Sulay A.
Chemerin (also known as tazarotene-induced gene 2 and retinoic acid receptor responder 2) has been identified as an adipokine that exerts effects on many biological processes, including adipogenesis, angiogenesis, inflammation, immune responses, and food intake. This variety of effects has led to its implication in obesity and co-morbidities including diabetes and a risk of cardiovascular disease. The biological effects are mostly mediated by a so-called G protein-coupled receptor, chemokine-like receptor 1 (CMKLR1). Given the association of chemerin with obesity and related diseases, we decided to study in detail the regulation of chemerin and CMKLR1 expression in white adipose tissue (WAT). Specifically, we focused on their expression levels in physiological and pathophysiological settings involved in energy balance: e.g., fasting, postnatal development, and gender. We used Sprague Dawley rats with different nutritional statuses, levels of hormonal deficiency, and states of development as well as ob/ob (leptin-deficient) mice. We analysed the protein expression of both the ligand and receptor (chemerin and CMKLR1) in gonadal WAT by western blotting. We found that chemerin and CMKLR1 protein levels were regulated in WAT by different conditions associated with metabolic changes such as nutritional status, sex steroids, pregnancy, and food composition. Our data indicate that regulation of the expression of this new adipokine and its receptor by nutritional status and gonadal hormones may be a part of the adaptive mechanisms related to altered fat mass and its metabolic complicatio
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publication Artículo científico (JournalArticle)

Sequential Exposure to Obesogenic Factors in Females Rats: From Physiological Changes to Lipid Metabolism in Liver and Mesenteric Adipose Tissue

  • Novelle, Marta G.
  • Vázquez, María J.
  • Peinado, Juan R.
  • Martinello, Kátia D.
  • López, Miguel
  • Luckman, Simon M.
  • Tena-Sempere, Manuel
  • Malagón, María M.
  • Nogueiras, Rubén
  • Diéguez, Carlos
During their lifetime, females are subjected to different nutritional and hormonal factors that could increase the risk of obesity and associated comorbidities. From early postnatal periods until the postmenopausal phase, exposure to over nutrition, high-energy diet and oestrogen deficiency, are considered as significant obesity risk factors in women. In this study, we assessed how key transitional life events and exposure to different nutrition influence energy homeostasis in a rat model. Specifically, we assessed the sequential exposure to postnatal over nutrition, high-fat diet (HFD) after weaning, followed later by ovariectomy (OVX; as a model of menopause). Each obesity risk factor increased significantly body weight (BW) and adiposity, with additive effects after sequential exposure. Increased energy intake in both HFD and/or OVX groups, and decreased locomotor activity and energy expenditure after OVX can explain these metabolic changes. Our study also documents decreased lipogenic pathway in mesenteric adipose tissue after HFD and/or OVX, independent of previous postnatal programming, yet only HFD evoked this effect in liver. In addition, we report an increase in the expression of the hepatic PEPCK depending on previous metabolic status. Overall, our results identify the impact of different risk factors, which will help in understanding the development of obesity in females.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Central Ceramide-Induced Hypothalamic Lipotoxicity and ER Stress Regulate Energy Balance

  • Contreras, Cristina
  • González García, Isabel
  • Martínez-Sánchez, Noelia
  • Seoane-Collazo, Patricia
  • Jacas, Jordi
  • Morgan, Donald A.
  • Serra i Cucurull, Dolors
  • Gallego, Rosalía
  • Gonzalez, Francisco
  • Casals, Núria
  • Nogueiras, Rubén
  • Rahmouni, Kamal
  • Diéguez, Carlos
  • López, Miguel
Hypothalamic endoplasmic reticulum (ER) stress is a key mechanism leading to obesity. Here, we demonstrate that ceramides induce lipotoxicity and hypothalamic ER stress, leading to sympathetic inhibition, reduced brown adipose tissue (BAT) thermogenesis, and weight gain. Genetic overexpression of the chaperone GRP78/BiP (glucoseregulated protein 78 kDa/binding immunoglobulin protein) in the ventromedial nucleus of the hypothalamus (VMH) abolishes ceramide action by reducing hypothalamic ER stress and increasing BAT thermogenesis, which leads to weight loss and improved glucose homeostasis. The pathophysiological relevance of this mechanism is demonstrated in obese Zucker rats, which show increased hypothalamic ceramide levels and ER stress. Overexpression of GRP78 in the VMH of these animals reduced body weight by increasing BAT thermogenesis as well as decreasing leptin and insulin resistance and hepatic steatosis. Overall, these data identify a triangulated signaling network involving central ceramides, hypothalamic lipotoxicity/ER stress, and BAT thermogenesis as a pathophysiological mechanism of obesity.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance

  • Bortolozzi, Analía
  • García-Rovés, Pablo M.
  • Gomis, Ramón
  • Zorzano, Antonio
  • Claret, Marc
Mitofusin 2 (MFN2) plays critical roles in both mitochondrial fusion and the establishment of mitochondria-endoplasmic reticulum (ER) interactions. Hypothalamic ER stress has emerged as a causative factor for the development of leptin resistance, but the underlying mechanisms are largely unknown. Here, we show that mitochondria-ER contacts in anorexigenic pro-opiomelanocortin (POMC) neurons in the hypothalamus are decreased in diet-induced obesity. POMC-specific ablation of Mfn2 resulted in loss of mitochondria-ER contacts, defective POMC processing, ER stress-induced leptin resistance, hyperphagia, reduced energy expenditure, and obesity. Pharmacological relieve of hypothalamic ER stress reversed these metabolic alterations. Our data establish MFN2 in POMC neurons as an essential regulator of systemic energy balance by fine-tuning the mitochondrial-ER axis homeostasis and function. This previously unrecognized role for MFN2 argues for a crucial involvement in mediating ER stress-induced leptin resistance. © 2013 Elsevier Inc., This work has been supported by: RecerCaixa Grant 2010ACUP_00275 (M.C.); EFSD/Lilly Fellowship Award (M.C.); Ministerio de Ciencia e Innovación (MICINN), Instituto de Salud Carlos III (ISCIII) Grant PI10/01074 (M.C.); MICINN Grant SAF2010-19527 (R.G.); Ministerio de Economia y Competitividad (MINECO) Grant BFU2012-35255 (RN); Xunta de Galicia Grant EM2012/039 and 2012-CP069 (R.N.); CIBERobn (R.N.); European Community’s Seventh Framework Programme Grant ERC-2011-StG-OBESITY53-281408 (R.N.); MINECO Grant SAF2008-03803 (A.Z.); Generalitat de Catalunya Grant 2009SGR915 (A.Z.); CIBERDEM (A.Z.); INTERREG IV-B-SUDOE-FEDER (DIOMED, SOE1/P1/E178) (A.Z.); European Commission Seventh Framework Programme (FP7), MITIN Grant HEALTH-F4-2008-223450 (A.Z.); MICINN Grant BFU2011- 24679 (P.M.G.-R.); ISCIII Grant PI10/00290 (A.B.). T.L.H. and M.O.D. are supported by NIH (DP1DK006850, R01AG040236, P01NS062686), American Diabetes Association, Helmholtz society (ICEMED) and by Conselho Nacional de Desenvolvimento Científico e Tecnológico (401476/2012-0, Brazil). M.S. is a recipient of an undergraduate grant from the University of Barcelona. M.C. is a recipient of a Miguel Servet contract (CP09/00233) from MICINN-ISCIII. P.M.G.-R. is a recipient of a Ramon y Cajal contract (RYC-2009-05158) from MICINN. Some of these grants are cofinanced by the European Regional Development Fund “A way to build Europe.” This work was carried out in part at the Esther Koplowitz Centre, Barcelona., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Chronic sympathoexcitation through loss of Vav3, a Rac1 activator, results in divergent effects on metabolic syndrome and obesity depending on diet

  • Menacho-Márquez, Mauricio
  • Nogueiras, Rubén
  • Fabbiano, Salvatore
  • Sauzeau, Vincent
  • Al-Massadi, Omar
  • Diéguez, Carlos
  • Bustelo, Xosé R.
The role of the sympathetic nervous system, stress, and hypertension in metabolic syndrome and obesity remains unclear. To clarify this issue, we utilized genetically engineered mice showing chronic sympathoexcitation and hypertension due to lack of Vav3, a Rac1 activator. Here, we report that these animals develop metabolic syndrome under chow diet. However, they show protection from metabolic syndrome and obesity under fatty diets. These effects are elicited by α1-adrenergic- and diet-dependent metabolic changes in liver and the α1/β3 adrenergic-mediated stimulation of brown adipocyte thermogenesis. These responses seem to be engaged by the local action of noradrenaline in target tissues rather than by long-range effects of adrenaline. By contrast, they are not triggered by low parasympathetic drive or the hypertensive state present in Vav3-deficient mice. These results indicate that the sympathetic system plays divergent roles in the etiology of metabolic diseases depending on food regimen, sympathoexcitation source, and disease stage., Work was supported by grants from the Spanish Ministry of Economy & Competitiveness to X.R.B. (SAF2009-07172, SAF2012-31371, RD06/0020/0001, RD12/0036/0002), R.N. (RYC-2008-02219, SAF2009-07049), and C.D. (BFU2011, CIBER de Fisiopatología de la Obesidad y Nutrición); the Galician Autonomous Government to R.N. (2010/14); and the European Union 7th Framework Program to R.N. (ERC-2011-StG-OBESITY53-281408, 245009) and C.D. (245009)., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Central Ceramide-Induced Hypothalamic Lipotoxicity and ER Stress Regulate Energy Balance

  • Contreras, Cristina
  • González García, Isabel
  • Martínez-Sánchez, Noelia
  • Seoane-Collazo, Patricia
  • Jacas, Jordi
  • Morgan, Donald A.
  • Serra i Cucurull, Dolors
  • Gallego, Rosalía
  • Gonzalez, Francisco
  • Casals, Núria
  • Nogueiras, Rubén
  • Rahmouni, Kamal
  • Diéguez, Carlos
  • López, Miguel
Hypothalamic endoplasmic reticulum (ER) stress is a key mechanism leading to obesity. Here, we demonstrate that ceramides induce lipotoxicity and hypothalamic ER stress, leading to sympathetic inhibition, reduced brown adipose tissue (BAT) thermogenesis, and weight gain. Genetic overexpression of the chaperone GRP78/BiP (glucoseregulated protein 78 kDa/binding immunoglobulin protein) in the ventromedial nucleus of the hypothalamus (VMH) abolishes ceramide action by reducing hypothalamic ER stress and increasing BAT thermogenesis, which leads to weight loss and improved glucose homeostasis. The pathophysiological relevance of this mechanism is demonstrated in obese Zucker rats, which show increased hypothalamic ceramide levels and ER stress. Overexpression of GRP78 in the VMH of these animals reduced body weight by increasing BAT thermogenesis as well as decreasing leptin and insulin resistance and hepatic steatosis. Overall, these data identify a triangulated signaling network involving central ceramides, hypothalamic lipotoxicity/ER stress, and BAT thermogenesis as a pathophysiological mechanism of obesity.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Melanin-concentrating hormone acts through hypothalamic kappa opioid system and p70S6K to stimulate acute food intake

  • Romero Picó, Amparo
  • Sanchez-Rebordelo, Estrella
  • Imbernon, Monica
  • Gónzalez-Touceda, David
  • Folgueira, Cintia
  • Senra, Ana
  • Fernø, Johan
  • Blouet, Clémence
  • Cabrera Ortega, Roberto
  • Gestel, Margriet van
  • Adan, Roger A.
  • López, Miguel
  • Maldonado, Rafael, 1961-
  • Nogueiras, Ruben
  • Diéguez, Carlos
Melanin-Concentrating Hormone (MCH) is one of the most relevant orexigenic factors specifically located in the lateral hypothalamic area (LHA), with its physiological relevance demonstrated in studies using several genetically manipulated mice models. However, the central mechanisms controlling MCH-induced hyperphagia remain largely uncharacterized. Here, we show that central injection of MCH in mice deficient for kappa opoid receptor (k-OR) failed to stimulate feeding. To determine the hypothalamic area responsible for this MCH/k-OR interaction, we performed virogenetic studies and found that downregulation of k-OR by adeno-associated viruses (shOprk1-AAV) in LHA, but not in other hypothalamic nuclei, was sufficient to block MCH-induced food intake. Next, we sought to investigate the molecular signaling pathway within the LHA that mediates acute central MCH stimulation of food intake. We found that MCH activates k-OR and that increased levels of phosphorylated extracellular signal regulated kinase (ERK) are associated with downregulation of phospho-S6 Ribosomal Protein. This effect was prevented when a pharmacological inhibitor of k-OR was co-administered with MCH. Finally, the specific activation of the direct upstream regulator of S6 (p70S6K) in the LHA attenuated MCH-stimulated food consumption. Our results reveal that lateral hypothalamic k-OR system modulates the orexigenic action of MCH via the p70S6K/S6 pathway., This work has been supported by grants from Ministerio de Economia y Competitividad (CD: BFU2014-55871; RN: BFU2015-70664-R; ML: SAF2015-71026-R), Xunta de Galicia (ML: 2015- CP079; RN: 2015-CP080 and PIE13/00024); Fundacion SEEN (RN); Helse Vest RHF (JF); Fundación AstraZeneca (RN: 2016-PO031); Centro de Investigacion Biomédica en Red (CIBER) de Fisiopatología de la Obesidad y Nutricion (CIBERobn). CIBERobn is an initiative of the Instituto de Salud Carlos III (ISCIII) of Spain which is supported by FEDER funds. The research leading to these results has also received funding from the European Community's Seventh Framework Programme under the following grant: RN: ERC StG281408